AXIS Clinicals LTD

raining, protocol adherence and leadership at significant cost advantages. Representing a vertically integrated CRO, we provide a collaborative and personalized approach to meet sponsor study requirements. Established in 2004, Axis offers trial management and monitoring, quality assurance, regulatory submissions, data management and biostatistics making us the assembly of a functional team ideally suited for clinical study. Our clients have ranged from big pharma majors to the emerging biotechnology sector. Our customized billing models help us add new clients besides retaining our recurring clientele. For more than 9+ years, AXIS has been offering clinical trial management service from small pilot studies to large multicenter international clinical trials for Phase II –IV. With committed result-oriented services in BA/BE, Phase II-IV and Clinical Data Management, we service trials for Global Generics, Pharmaceuticals and Biotech industry. Our greatest asset is our dedicated team of experienced clinical research professionals besides excellent infrastructure providing competence across the drug development lifecycle, empowering science and technology to address global realities and patients’ needs. AXIS is equipped with modern facilities and 350+ dedicated full-time professionals to ensure the quick turnaround time with high quality. The company has successfully completed 1500+ clinical studies, 300+ ANDA completed studies, 50+ product approvals, 38+ global regulatory audits and 50+ global and national sponsor audits. Our facilities are accredited by DCGI (Drugs Controller General, India), NABL (National Accreditation Board for Testing and Calibration Laboratories - ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA, Turkey- MOH, Mexican COFEPRIS and France AFSSAPS. Furthermore, Axis conforms to ICH and CDSCO-GCP & GLP Guidelines.